Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes

Abstract

Acquired thrombocytopenia was common after TAVR and was mostly resolved at patient discharge. The severity of thrombocytopenia after TAVR could be used as an excellent, easily obtainable, marker for worse short- and long-term outcomes after the procedure.